Updated IMPLANON NXT Procedures Statement

SHINE SA, September 2020

The contraceptive implant (Implanon NXT) is one of the most effective contraceptives available. Along with the hormonal and copper IUDs, it is classified as Long Acting Reversible Contraception (LARC) which are recommended as first-line options for all people choosing to use contraception.

SHINE SA wish to alert clinicians to important updated information about Implanon NXT procedures following an update of the product information in January 2020. These changes have been made to avoid the large blood vessels and nerves within and around the sulcus between biceps and triceps and reflect published research.

Free online event – What Is Your Vision: The Future Of Abortion Care In Australia

Children by ChoiceFamily Planning NT, I Had One Too1800 My OptionsOur Bodies Our ChoicesSouth Australian Abortion Action CoalitionSexual Health Quarters WASPHERE and Women’s Health Tasmania, September 2020

What Is Your Vision: The Future Of Abortion Care In Australia Event Banner

Event time and date: Mon 28th Sep 2020, 7:00 pm – 8:15 pm AEST (NB: this event starts at 6.30 PM Adelaide Time)

About the event

Gina Rushton will be chatting to health consumers with lived experience, abortion care providers, advocates, policymakers, and you the audience about what the future of abortion care should and could look like in Australia.

This event will be exploring the Australian abortion landscape, recognising that each State and Territory has it’s own legal, cultural and practice context.

Our panellists:

  • Chrissie Bernasconi – Health Consumer
  • Dr Sarah McEwan – Wiradjuri woman and Medical Doctor
  • Hon Dr Sharman Stone – Professor of Practice for Gender, Peace and Security, Monash University
  • Dr Mark Farrugia – Rural GP and MTOP provider
  • Professor Deb Bateson – Medical Director, Family Planning NSW
  • Dr Suzanne Belton – Medical Anthropologist and Midwife

About the facilitator

Gina Rushton is a journalist who has written for BuzzFeed News, The Guardian, The Monthly, The Saturday Paper, Crikey, PRIMER and The Australian. She is a Royal Australian and New Zealand College of Obstetricians and Gynaecologists media excellence award winner and Australian Human Rights Commission media award finalist for her coverage of reproductive rights.

About International Safe Abortion Day

28th of September is International Safe Abortion Day, the herstory of this day begins in Latin America and the Caribbean where women’s groups have been mobilizing around September 28 for the last two decades to demand their governments decriminalize abortions, provide access to safe and affordable abortion services and to end stigma and discrimination towards people who choose to have abortions.

Extra info

There will be an opportunity to ask questions in a Q&A – You can also submit a question prior to the event when you register.

This event is offered in accordance with Children by Choice’s pro-choice framework. Children by Choice reserve the right to refuse registrations and remove individuals from the event.

RACGP offers new suite of IUD resources

RACGP, 25th August 2020

The newly released suite consists of five intrauterine device (IUD) resources, including a checklist and patient confirmation form, patient pre- and post-insertion checklist, practitioner checklist and disclaimer. Current evidence-based options for pain relief during IUD procedures are provided as an appendix.

Dr Amy Moten, Chair of the RACGP Specific Interests Sexual Health Medicine network, led development of the resources, which she says are designed to provide guidance and support to all Australian practitioners.

Sexual and reproductive health a COVID-19 priority (Statement)

Burnet Institute, 28 May, 2020

Burnet Institute is a member of a consortium of Australian-based non-governmental organisations (NGOs) and academic institutes concerned about the detrimental effects of the COVID-19 pandemic on the sexual and reproductive health and rights of women and girls globally.

The International Sexual and Reproductive Health and Rights Consortium, which includes Save the Children, Family Planning NSW, CARE Australia, The Nossal Institute for Global Health, and Médecins Sans Frontières Australia, is calling on the Australian Government to prioritise the needs of women and girls in its response to COVID-19.

Collectively, the consortium works across 160 countries to champion universal access to sexual and reproductive health and rights.

It’s concerned that women and girls across the globe are struggling to access critical sexual and reproductive health care, citing evidence that COVID-19 lockdowns are likely to cause millions of unplanned pregnancies.

In the Pacific, travel to rural and remote areas have been curtailed, and physical distancing requirements have forced the cancellation of most group training on sexual and reproductive rights.

A recent UNFPA report determined that a six-month lockdown could mean 47 million women and girls globally cannot access contraception, and seven million will become pregnant.

The consortium has issued a joint statement setting out priorities to ensure Australia’s global response to COVID-19 meets the critical needs of all women and girls, including:

  • Recognise and respond to the gendered impacts of the pandemic, and the increased risk to women and girls from gender-based violence and other harmful practices
  • Improve the supply of contraceptives and menstrual health products which are being impacted by the strain and disruption on global supply chains
  • Increase flexibility in delivering sexual and reproductive health services during lockdown using innovative health delivery models such as task-sharing, tele-health and pharmacy distribution
  • Support sexual and reproductive health workers and clinics to continue delivering services sagely with access to personal protective equipment as well as training on how to refer, test or diagnose COVID-19.

 

U.S. FDA Approves Evofem Biosciences’ Phexxi™, the First Non-Hormonal Prescription Gel for the Prevention of Pregnancy

Evofem Biosciences via PRNewswire, May 22nd 2020 

Evofem Biosciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Phexxi™ (lactic acid, citric acid and potassium bitartrate) vaginal gel for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception.

Phexxi is the first non-hormonal, on-demand, vaginal pH regulator contraceptive designed to maintain vaginal pH within the normal range of 3.5 to 4.5 – an acidic environment that is inhospitable to sperm.

Situational Report: Sexual and Reproductive Health Rights in Australia

Marie Stopes Australia, Updated 17 April 2020

Situational Report: Sexual and Reproductive Health Rights in Australia – A request for collaboration and action to maintain contraceptive and abortion care throughout the SARS-COV-2 / COVID-19 pandemic

Executive Summary

We are in a context of increased risk of unplanned pregnancy, reproductive coercion, sexually transmitted infections, lack of pregnancy options and a multitude of barriers to healthcare. Access to contraception and abortion throughout the pandemic will mitigate broader public health risks for years to come. 
.
At Marie Stopes Australia, during the pandemic we have had to:

 Cancel surgical abortion care lists- meaning women and pregnant people have had to continue with their pregnancies or are likely to seek a termination at a later gestation
 Reduce our national gestational limit for surgical abortion to 22 weeks
 Face increased costs in the provision of regional healthcare, having no other option than to charter private flights for clinical staff
 Continuously scramble for Personal Protective Equipment (PPE)
 Reduce in-clinic list capacity to enable physical distancing
 Reduce contraceptive services in order to prioritise abortion access
 Reduce financial support for clients experiencing financial hardship
 Face increased risk of staff fatigue and burn out
 Evolve models of care in an effort to maintain access to care. To address this situation, we need to review legislation and policy, evolve models of care, maintain people’s rights to access care and make healthcare more affordable.

Key recommendations at this point in the pandemic include:
 All Governments, health and hospital services, and health clinics must consider abortion an essential service with Category 1 classification
 Provide access to medical abortion via telehealth for people living in South Australia
 Increase medical abortion provision to 70 days/10 weeks gestation, supported by the  Pharmaceutical Benefits Scheme (PBS)
 All accredited sexual and reproductive healthcare providers should have access to the National Medical Stockpile for PPE
 Intrastate travel support is needed for clinical staff in order to maintain surgical abortion provision in regional and remote clinics
 Do not criminalise women and pregnant people who attempt unsafe abortion

[This report contains] further detail on these points and a longer list of recommendations that Australia will need to consider in o order to maintain sexual and reproductive health
rights throughout the pandemic.